A New Method to Model and Predict Progression Free Survival Based on Tumor Growth Dynamics

por Yu, Jiajie, Wang, Nina, Kågedal, Matts
Publicado 2020

Analysis of Longitudinal‐Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models

por Lu, Tong, Yang, Yujie, Jin, Jin Y., Kågedal, Matts
Publicado 2020

A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score

por Moein, Anita, Langenhorst, Jurgen, Plan, Elodie L., Jin, Jin Y., Kågedal, Matts, Kassir, Nastya
Publicado 2023

Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer Therapy

por Reyner, Eric, Lum, Bert, Jing, Jing, Kagedal, Matts, Ware, Joseph A., Dickmann, Leslie J.
Publicado 2019

Autoradiographic Mapping of 5-H T (1B/1D) Binding Sites in the Rhesus Monkey Brain Using [carbonyl-(11)C]zolmitriptan

por Lindhe, Örjan, Almqvist, Per, Kågedal, Matts, Gustafsson, Sven-Åke, Bergström, Mats, Nilsson, Dag, Antoni, Gunnar
Publicado 2011

A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis

por Kawakatsu, Sonoko, Zhu, Rui, Zhang, Wenhui, Tang, Meina T., Lu, Tong, Quartino, Angelica L., Kågedal, Matts
Publicado 2021

Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conj...

por Liao, Michael Z., Lu, Dan, Kågedal, Matts, Miles, Dale, Samineni, Divya, Liu, Stephanie N., Li, Chunze
Publicado 2021

Time‐to‐Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine‐Citrulline‐Monomethylauristatin E Antibody–Drug Conjugates

por Kågedal, Matts, Samineni, Divya, Gillespie, William R., Lu, Dan, Fine, Bernard M., Girish, Sandhya, Li, Chunze, Jin, Jin Y.
Publicado 2019

Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates

por Li, Chunze, Chen, Shang‐Chiung, Chen, Yuan, Girish, Sandhya, Kågedal, Matts, Lu, Dan, Lu, Tong, Samineni, Divya, Jin, Jin Y.
Publicado 2020

Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-p...

por Wang, Bei, Deng, Rong, Hennig, Stefanie, Badovinac Crnjevic, Tanja, Kaewphluk, Monika, Kågedal, Matts, Quartino, Angelica L., Girish, Sandhya, Li, Chunze, Kirschbrown, Whitney P.
Publicado 2021

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration

por Wykoff, Charles C., Campochiaro, Peter A., Pieramici, Dante J., Khanani, Arshad M., Gune, Shamika, Maia, Mauricio, Kågedal, Matts, Ding, Han Ting, Maass, Katie F.
Publicado 2022

Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study

por Kirschbrown, Whitney P., Wynne, Chris, Kågedal, Matts, Wada, Russ, Li, Hanbin, Wang, Bei, Nijem, Ihsan, Badovinac Crnjevic, Tanja, Gasser, Helena, Heeson, Sarah, Eng‐Wong, Jennifer, Garg, Amit
Publicado 2018

Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study

por Kirschbrown, Whitney P., Kågedal, Matts, Wang, Bei, Lindbom, Lars, Knott, Adam, Mack, Rachelle, Monemi, Sharareh, Nijem, Ihsan, Girish, Sandhya, Freeman, Christie, Fumagalli, Debora, McConnell, Robin, Jerusalem, Guy, Twelves, Chris, Baselga, José, von Minckwitz, Gunter, Bines, José, Garg, Amit
Publicado 2019